Clinical Trials Directory

Trials / Conditions / Pancreatic Ductal Carcinoma

Pancreatic Ductal Carcinoma

8 registered clinical trials studyying Pancreatic Ductal Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingUsing Tumor Models to Determine Treatments
NCT06813079
University Health Network, TorontoPhase 2
CompletedA Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
NCT05293496
MacroGenicsPhase 1
RecruitingPhase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutat
NCT05288205
Allist Pharmaceuticals, Inc.Phase 1 / Phase 2
CompletedRecurrence After Whipple's (RAW) Study
NCT04596865
University Hospital Plymouth NHS Trust—
CompletedA Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China
NCT04121286
Allist Pharmaceuticals, Inc.Phase 1
CompletedA First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
NCT04045496
Jacobio Pharmaceuticals Co., Ltd.Phase 1
TerminatedA Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compa
NCT02715804
Halozyme TherapeuticsPhase 3
TerminatedPhase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancre
NCT02243007
Massachusetts General HospitalPhase 2